Literature DB >> 30912918

Engineering the PP7 Virus Capsid as a Peptide Display Platform.

Liangjun Zhao, Mykhailo Kopylov1, Clinton S Potter1, Bridget Carragher1, M G Finn.   

Abstract

As self-assembling polyvalent nanoscale structures that can tolerate substantial genetic and chemical modification, virus-like particles are useful in a variety of fields. Here we describe the genetic modification and structural characterization of the Leviviridae PP7 capsid protein as a platform for the presentation of functional polypeptides. This particle was shown to tolerate the display of sequences from 1 kDa (a cell penetrating peptide) to 14 kDa (the Fc-binding double Z-domain) on its exterior surface as C-terminal genetic fusions to the coat protein. In addition, a dimeric construct allowed the presentation of exogenous loops between capsid monomers and the simultaneous presentation of two different peptides at different positions on the icosahedral structure. The PP7 particle is thereby significantly more tolerant of these types of polypeptide additions than Qβ and MS2, the other Leviviridae-derived VLPs in common use.

Entities:  

Keywords:  cryo-electron microscopy; packaged enzymes; peptide display; protein nanoparticles; virus-like particles

Year:  2019        PMID: 30912918      PMCID: PMC6991139          DOI: 10.1021/acsnano.8b09683

Source DB:  PubMed          Journal:  ACS Nano        ISSN: 1936-0851            Impact factor:   15.881


  82 in total

1.  Baculoviral display of functional scFv and synthetic IgG-binding domains.

Authors:  D G Mottershead; K Alfthan; K Ojala; K Takkinen; C Oker-Blom
Journal:  Biochem Biophys Res Commun       Date:  2000-08-18       Impact factor: 3.575

2.  CD8+ T cells specific for immunodominant trans-sialidase epitopes contribute to control of Trypanosoma cruzi infection but are not required for resistance.

Authors:  Charles S Rosenberg; Dianya L Martin; Rick L Tarleton
Journal:  J Immunol       Date:  2010-06-07       Impact factor: 5.422

3.  Recombinant human epidermal growth factor inclusion body solubilization and refolding at large scale using expanded-bed adsorption chromatography from Escherichia coli.

Authors:  K Sharma; P V Cherish Babu; P Sasidhar; V K Srinivas; V Krishna Mohan; Ella Krishna
Journal:  Protein Expr Purif       Date:  2008-03-16       Impact factor: 1.650

Review 4.  RNA phage Q beta coat protein as a carrier for foreign epitopes.

Authors:  T M Kozlovska; I Cielens; I Vasiljeva; A Strelnikova; A Kazaks; A Dislers; D Dreilina; V Ose; I Gusars; P Pumpens
Journal:  Intervirology       Date:  1996       Impact factor: 1.763

Review 5.  Virus Like Particles as Immunogens and Universal Nanocarriers.

Authors:  Antonina Naskalska; Krzysztof Pyrć
Journal:  Pol J Microbiol       Date:  2015

6.  Establishment of MicroRNA delivery system by PP7 bacteriophage-like particles carrying cell-penetrating peptide.

Authors:  Yanli Sun; Yanhua Sun; Ronglan Zhao
Journal:  J Biosci Bioeng       Date:  2017-04-22       Impact factor: 2.894

Review 7.  Inhibitory Antibodies Targeting Emerging Viruses: Advancements and Mechanisms.

Authors:  Jing Jin; Graham Simmons
Journal:  Clin Vaccine Immunol       Date:  2016-07-05

8.  Identification of an Immunogenic Mimic of a Conserved Epitope on the Plasmodium falciparum Blood Stage Antigen AMA1 Using Virus-Like Particle (VLP) Peptide Display.

Authors:  Erin Crossey; Kathryn Frietze; David L Narum; David S Peabody; Bryce Chackerian
Journal:  PLoS One       Date:  2015-07-06       Impact factor: 3.240

9.  New tools for automated high-resolution cryo-EM structure determination in RELION-3.

Authors:  Jasenko Zivanov; Takanori Nakane; Björn O Forsberg; Dari Kimanius; Wim Jh Hagen; Erik Lindahl; Sjors Hw Scheres
Journal:  Elife       Date:  2018-11-09       Impact factor: 8.140

Review 10.  Virus-like particles as a highly efficient vaccine platform: diversity of targets and production systems and advances in clinical development.

Authors:  Natasha Kushnir; Stephen J Streatfield; Vidadi Yusibov
Journal:  Vaccine       Date:  2012-11-06       Impact factor: 3.641

View more
  12 in total

Review 1.  Mechanisms of cellular and humoral immunity through the lens of VLP-based vaccines.

Authors:  Hunter McFall-Boegeman; Xuefei Huang
Journal:  Expert Rev Vaccines       Date:  2022-01-24       Impact factor: 5.217

2.  Controlled Modular Multivalent Presentation of the CD40 Ligand on P22 Virus-like Particles Leads to Tunable Amplification of CD40 Signaling.

Authors:  Cheri Peyton Goodall; Benjamin Schwarz; Ekaterina Selivanovitch; John Avera; Joseph Wang; Heini Miettinen; Trevor Douglas
Journal:  ACS Appl Bio Mater       Date:  2021-11-10

3.  cDNA-Derived RNA Phage Assembly Reveals Critical Residues in the Maturation Protein of the Pseudomonas aeruginosa Leviphage PP7.

Authors:  Eun Sook Kim; Jae-Yeol Lee; Chanseop Park; Se-Jeong Ahn; Hee-Won Bae; You-Hee Cho
Journal:  J Virol       Date:  2021-01-13       Impact factor: 5.103

4.  Rapid development of neutralizing and diagnostic SARS-COV-2 mouse monoclonal antibodies.

Authors:  Xiaoling Tang; Joo R Lee; Asiya Chida; Asheley P Chapman; Kristina Mercer; Rebekah E Wharton; Markus Kainulainen; Jennifer L Harcourt; Roosecelis B Martines; Michelle Schroeder; Liangjun Zhao; Anton Bryksin; Bin Zhou; Eric Bergeron; Brigid C Bollweg; Azaibi Tamin; Natalie Thornburg; David E Wentworth; David Petway; Dennis A Bagarozzi; M G Finn; Jason M Goldstein
Journal:  Sci Rep       Date:  2021-05-06       Impact factor: 4.379

5.  Single-Point Mutations in Qβ Virus-like Particles Change Binding to Cells.

Authors:  Marisa L Martino; Stephen N Crooke; Marianne Manchester; M G Finn
Journal:  Biomacromolecules       Date:  2021-07-12       Impact factor: 6.978

Review 6.  Viral nanoparticles for drug delivery, imaging, immunotherapy, and theranostic applications.

Authors:  Young Hun Chung; Hui Cai; Nicole F Steinmetz
Journal:  Adv Drug Deliv Rev       Date:  2020-06-27       Impact factor: 15.470

7.  Bacteriophage MS2 displays unreported capsid variability assembling T = 4 and mixed capsids.

Authors:  Natàlia de Martín Garrido; Michael A Crone; Kailash Ramlaul; Paul A Simpson; Paul S Freemont; Christopher H S Aylett
Journal:  Mol Microbiol       Date:  2019-11-05       Impact factor: 3.501

Review 8.  RNA Phage VLP-Based Vaccine Platforms.

Authors:  David S Peabody; Julianne Peabody; Steven B Bradfute; Bryce Chackerian
Journal:  Pharmaceuticals (Basel)       Date:  2021-08-04

Review 9.  Stronger Together: Multivalent Phage Capsids Inhibit Virus Entry.

Authors:  Iván Gallego; Irene Lostalé-Seijo; Javier Montenegro
Journal:  Chembiochem       Date:  2020-09-30       Impact factor: 3.461

Review 10.  Recent progress in targeted delivery vectors based on biomimetic nanoparticles.

Authors:  Li Chen; Weiqi Hong; Wenyan Ren; Ting Xu; Zhiyong Qian; Zhiyao He
Journal:  Signal Transduct Target Ther       Date:  2021-06-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.